NEW YORK (GenomeWeb) – Abbott said today that it has filed a complaint in the Delaware Chancery Court to terminate its proposed $5.8 billion acquisition of Alere.

In a statement, Abbott said that it wants out of the deal because of "the substantial loss in Alere's value following the merger agreement," and what it described as adverse events that materially change Alere's long-term prospects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.